When Hospital Clínic de Barcelona initiated a project to digitize its pathology department, it anticipated greater efficiency, more convenient access to studies and easier collaboration among care team members.
While mRNA is now well-connected to Pfizer or Moderna, saRNA is a more obscure, early-stage vaccine technology - now, scientists in the UK have data suggesting that saRNA COVID vaccines could work well for most people.
A study released yesterday (28 June) found that it would be safe to mix Pfizer and AstraZeneca doses, which could speed up UK vaccine roll-out if adopted.
Indiana University School of Medicine researchers are attempting to use magnetic nanoparticles to develop a cure for neurological disorders from epilepsy to Alzheimer's - without any invasive or genetic treatment.
The UK Government will begin rollout of a third COVID dose for over-50s and vulnerable individuals, with the NHS given the go-ahead to create their pre-winter vaccination plan.
A team from Missouri University of Science and Technology, focus on water citizen science, including comment on monitoring water quality with affordable, open-source sensors & generating shared knowledge in social media.
As your specialist in Acute Care, Draeger Medical UK Ltd is focused on providing protective therapy solutions in the operating room, intensive care unit and neonatal intensive care unit. The aim has always been to improve clinical outcomes and reduce risks in acute care; which has never been truer than in the time of a global pandemic.
Charles Taylor, Founder and Chief Technology Officer at HeartFlow, explores how artificial intelligence (AI) is helping to fix the gender disparities in healthcare.
Dr Faz Chowdhury, CEO at Nemaura Medical (Nasdaq: NMRD), aims to stem the tide of the onset of diabetes and help to manage and reverse Type 2 diabetes using the world’s first daily-wear non-invasive CGM technology.
The World Health Organisation on Friday (18 June) said that the Delta variant, originating in India, would be globally dominant due to "significantly increased transmissibility".
Here, Fraunhofer Germany discuss how COVID-19 has driven the adoption of digital health technologies, and offers solutions aiding healthcare professionals to keep up.
The German-made CureVac vaccine has given a result of 47% efficacy, much lower than expected - now, the proposed delivery of 225 million doses to the EU is at risk.
Over half of global cardiovascular disease (CVD) deaths in 2019 happened in Asia - now, scientists are drawing attention to rapidly climbing figures, as heart issues continue to be a risk factor for severe COVID.
